LifeCycle Pharma A/S
LifeCycle Pharma Moves LCP-Tacro™ into Clinical Phase 3
Published in Biotech Business Week, January 12th, 2009
LifeCycle Pharma A/S (OMX:LCP) announced the enrollment of the first patient in it’s Phase 3 clinical trial program for use of LCP-Tacro™ in the prevention of organ rejection in stable kidney transplant patients. The clinical trial protocol has been reviewed by FDA, and LCP expects to enroll approximately 300 stable kidney transplant patients in the program. The study will be conducted at approximately 50 sites in U.S. and Europe and the clinical trial results are expected by second half of 2010.
After having demonstrated positive Phase 2 pharmacokinetic (PK) data in stable transplant patients earlier this year, LCP had successful discussions with the U.S. Food and Drug...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Biotech Business Week
More Articles from Biotech Business Week
- American Journal of Pathology
Potential therapy for congenital muscular dystrophy - American Journal of Pathology
Safe new therapy for genetic heart disease - American Thoracic Society
Anti-fungal drug offers great benefits to some with severe asthma - Case Western Reserve University
Case Western Reserve finds mechanism underlying alt. splicing of premessenger RNA into messenger RNA - Research
Impaired energy metabolism linked with initiation of plaques in Alzheimer's brain - Research
Recipe for capturing authentic embryonic stem cells may apply to any mammal, study suggests - More from this issue of Biotech Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
